Cite
MLA Citation
R. Bomben et al.. “P596: CLINICAL IMPACT OF TP53 DISRUPTION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH A BCR INHIBITOR. A CAMPUS CLL EXPERIENCE.” HemaSphere, vol. 6, n.d., pp. 495–496. http://access.bl.uk/ark:/81055/vdc_100159756420.0x000010